Olympus Corporation of the Americas has recalled 3 units of the Quest Spectrum 3 Fluorescent Imaging System because the device may malfunction when exposed to electromagnetic interference. This system is used by surgeons to visualize blood flow during plastic and reconstructive surgeries. If the device fails during a procedure, it could lead to surgical delays or require additional medical intervention to complete the surgery safely.
The device does not meet international standards for electromagnetic compatibility, meaning other electronic equipment could cause it to stop working. A malfunction during surgery could result in prolonged anesthesia for the patient or the need for additional medical steps to assess tissue health.
Used for visual assessment of blood flow and tissue perfusion during plastic and reconstructive surgeries.
No distribution reported in the USA for this model.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.